glp 1 development history The expanding landscape of GLP-1 medicines Structural pharmacology and mechanisms of

In a retrospective analysis of more than 60,000 patients aged 40 years and older, researchers found that individuals initiating treatment with GLP-1 receptor agonists had better long-term neurological and survival outcomes than those taking other classes of antidiabetic drugs

sciencedirect.com Pharmacokinetics: early studies (including dog PK) explore exposure at microgram-scale dosing

Clinical Nutrition, 39(5), 1391-1400

That share climbed to 81% among people currently taking one, and also rose with age: Gen Z: 51% Millennials: 52% Gen X: 67% Baby boomers: 80% What It Costs to Stay on a GLP-1 For people already on treatment, holding on can mean making other tradeoffs

Staying hydrated, prioritizing protein, and maintaining balanced meals may help reduce these symptoms

10.1016/j.molcel.2018.07.019 Mol